IPO ChampIPO Insights
IPO Champ LogoIPO Champ Logo

IPOs

IPO Calendar
GMP Tracker
Subscription Status
Allotment Status
Stock Broker
  • Follow us on Instagram
  • Follow us on Facebook
  • Follow us on Threads
  • Follow us on YouTube
  • Follow us on Telegram
  • Follow us on WhatsApp
HomeIPOQ-Line Biotech

About Q-Line Biotech

Founded in 2010, Q-Line Biotech Ltd. is involved in the development, manufacture and commercialization of various reagents (kits and POC devices) and consumables and manufacturing, importation, and supply of diagnostic instruments for different healthcare requirements. Q-Line Biotech Ltd. has been providing diagnostic instruments and IVD products for different healthcare requirements since 2013 either directly or via our distributor(s) primarily to diagnostic service organizations, hospitals, and medical colleges. Q-Line Biotech Ltd.'s manufacturing categories comprise indigenous manufacture of reagents including Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and Others (POC Devices & Rapid Tests) and supply/ manufacture of in vitro diagnostics (IVD), pathology equipment and devices. As of March 31, 2025, the company employed 313 permanent employees.

Checklist Quality Analysis

Live IPOs

National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
Open  Close17th Sep 2026 - 21st Sep 2026
Issue Size22561.57 Cr
Min. Qty8 Shares
Issue Price₹ 1700.00
Live IPO
Antala Industries logo

Antala Industries

SME
Open  Close29th Oct 2026 - 5th Nov 2026
Issue Size22.98 Cr
Min. Qty2000 Shares
Issue Price₹ 62.00
Live IPO
Companies NameOpen - CloseIssue SizeMin. QtyIssue PriceApply
National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
17th Sep 2026 - 21st Sep 202622561.57 Cr8 Shares₹ 1700.00
Antala Industries logo

Antala Industries

SME
29th Oct 2026 - 5th Nov 202622.98 Cr2000 Shares₹ 62.00
See All Live IPOs
IPO Champ LogoIPO Champ Logo

IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO CalendarGMP TrackerSubscription StatusAllotment Status

IPOs

All IPOsLive IPOsUpcoming IPOsClosed IPOsListed IPOs

Resources

NewseBooks

Company

HomeAbout UsPrivacy PolicyTerms of Service

About IPO Champ

IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.

Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Champ. All rights reserved.

Want to stay updated?Subscribe to our newsletter

Q-Line Biotech

Q-Line Biotech

Open Date

May 21, 2026

Close Date

May 25, 2026

listed

Min Investment

₹2,74,400

Lot Size

400 Shares

Issue Size

₹214.48 Cr

Price Range

₹326 - ₹326

Listing Date

May 29, 2026

IPO Doc

RHP PDF

Revenue Growth

Company Valuation

Earning Expansion

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

₹105(+32.21%)GMP
15.31%Prediction Listing Gain

Grey Market Premium (GMP) Trend

Q-Line Biotech IPO - Issue Objectives

The company will utilise ₹93.50 crore for working capital requirement of the business. The company will use ₹90 crore for repayment of borrowings. Part of the IPO proceeds will be used for general corporate purposes and issue expenses

Working capital expenditure

43.6%

Repayment of borrowings

42.06%

General corporate purposes

14.25%

1

Working capital expenditure

The company will utilise ₹93.50 crore for working capital requirement of the business.

43.60%
2

Repayment of borrowings

The company will use ₹90 crore for repayment of borrowings.

42.06%
3

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes and issue expenses

14.25%

IPO Subscription Status

QIB
123.94x
NII
146.33x
Total
102.49x

Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).

Financials of Q-Line Biotech

In Cr.

Contact Details

Q-Line Biotech

298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh - 226012.

+915222435570
compliance@qlinebiotech.com
https://qlinebiotech.com

Q-Line Biotech IPO - FAQs

Q-Line Biotech IPO is a SME IPO. The issue is priced at 326-₹343. The minimum order quantity is 400 Shares. The IPO opens on 21 May, and closes on 25 May. TBA is the registrar for the IPO. The shares are proposed to be listed on SME.








IPO Timeline

  • Pre Apply2026-05-20
  • Bidding Starts2026-05-21
  • Bidding Ends2026-05-25
  • Allotment Finalisation2026-05-26
  • Release of Funds2026-05-27
  • Demat Transfer2026-05-27
  • Listing2026-05-29